Clinical Trials Browser

Phase 2 × Pafolacianine × 1 year × Clear all

NCT06434909 2025-10-21

CYTALUX™for the Intraoperative Imaging of Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms